Get the Stockscreener App
33.49
5.15%
1.64
After Hours:
32.83
-0.66
-1.97%
Vericel Corp stock is traded at $33.49, with a volume of 657.47K.
It is up +5.15% in the last 24 hours and up +4.07% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$31.85
Open:
$32.21
24h Volume:
657.47K
Relative Volume:
0.94
Market Cap:
$1.69B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
478.43
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-0.74%
1M Performance:
+4.07%
6M Performance:
-18.81%
1Y Performance:
-19.67%
1-Day Range:
$31.63
$33.51
1-Week Range:
$31.34
$34.55
52-Week Range:
$29.24
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
33.49 | 1.61B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Can Vericel Corporation stock sustain market leadershipJuly 2025 Levels & AI Based Buy and Sell Signals - newser.com
Measuring Vericel Corporation’s beta against major indicesVolume Spike & Daily Momentum Trading Reports - newser.com
Brokerages Set Vericel Corporation (NASDAQ:VCEL) PT at $60.40 - Defense World
Did Vericel's (VCEL) Strong Earnings Upside Just Shift Its Growth and Investment Narrative? - simplywall.st
Truist Financial Corp Buys 599 Shares of Vericel Corporation $VCEL - Defense World
Vericel (NASDAQ:VCEL) Receives "Sell (D+)" Rating from Weiss Ratings - MarketBeat
What moving averages say about Vericel Corporation2025 Top Decliners & Consistent Return Investment Signals - newser.com
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Unique Financial Metrics - Markets Mojo
Will Vericel Corporation see short term momentum2025 AllTime Highs & Growth Focused Entry Reports - newser.com
What data driven models say about Vericel Corporation’s futureEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
State of Alaska Department of Revenue Has $1.28 Million Stock Position in Vericel Corporation $VCEL - Defense World
Vericel Corporation $VCEL Shares Purchased by PFG Investments LLC - MarketBeat
Assessing Vericel (VCEL) Valuation After Recent Share Price Volatility - simplywall.st
Why Vericel Corporation (ATQP) stock gets analyst attention2025 Top Decliners & Expert Approved Trade Ideas - newser.com
GAMMA Investing LLC Cuts Holdings in Vericel Corporation $VCEL - Defense World
Park Avenue Securities LLC Invests $243,000 in Vericel Corporation $VCEL - Defense World
Real time breakdown of Vericel Corporation stock performanceFed Meeting & High Accuracy Swing Entry Alerts - newser.com
How to manage a losing position in Vericel CorporationCPI Data & Community Consensus Stock Picks - newser.com
What does recent volatility data suggest for Vericel CorporationWeekly Gains Report & Growth Focused Entry Point Reports - newser.com
Can Vericel Corporation (ATQP) stock survive global slowdownPrice Action & Precise Entry and Exit Recommendations - newser.com
Does Vericel Corporation show high probability of reboundJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
What technical models suggest about Vericel Corporation’s comebackPortfolio Growth Summary & Real-Time Stock Price Movement Reports - newser.com
Vericel director Robert Zerbe sells $156,250 in stock - MSN
Vericel Corp. Experiences Valuation Adjustment Amid Unique Market Dynamics and Performance Metrics - Markets Mojo
Understanding Vericel Corporation’s price movementAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com
Will Vericel Corporation benefit from macro trendsWall Street Watch & Weekly Top Gainers Trade List - newser.com
Vericel Corp. Hits New 52-Week Low at $29.24 Amidst Declining Performance - Markets Mojo
Vericel Corporation $VCEL Shares Acquired by Congress Asset Management Co. - Defense World
Vericel (NASDAQ:VCEL) Hits New 12-Month LowTime to Sell? - MarketBeat
Vericel stock hits 52-week low at 29.77 USD By Investing.com - Investing.com South Africa
Vericel stock hits 52-week low at 29.77 USD - Investing.com India
Kopp Family Office LLC Sells 8,554 Shares of Vericel Corporation $VCEL - MarketBeat
How to build a custom watchlist for Vericel CorporationQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Diversified Trust Co Grows Stock Holdings in Vericel Corporation $VCEL - Defense World
Voya Investment Management LLC Purchases 10,048 Shares of Vericel Corporation $VCEL - Defense World
Strs Ohio Takes Position in Vericel Corporation $VCEL - MarketBeat
Vericel Corporation stock trend forecastQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Vericel Corp. Experiences Revision in Its Stock Evaluation Amidst Unique Market Metrics - Markets Mojo
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vericel Corp Stock (VCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Sep 02 '25 |
Option Exercise |
18.00 |
10,000 |
180,000 |
76,363 |
| Hopper Jonathan Mark | Chief Medical Officer |
Sep 02 '25 |
Sale |
35.77 |
10,000 |
357,700 |
66,363 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):